CRD summary
The study objective was to assess the cost-effectiveness of adherence therapy for people with schizophrenia. The authors concluded that adherence therapy was unlikely to be cost-effective when compared to an active treatment. Study reporting and methodology was good. The authors conclusions appear to be appropriate.